A Study to Assess Change in Disease Activity and Adverse Events of Adalimumab in Chinese Participants Requiring High Dose Corticosteroids for Active Non-Infectious Intermediate, Posterior, or Pan-Uveitis

Clinical trial NCT05414201 · COMPLETED

Trial details

NCT number: NCT05414201
Sponsor: AbbVie
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Non-infectious Intermediate Posterior- or Pan-uveitis

Start date: 2022-07-07
Primary completion: 2024-06-10
Enrollment: 87

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.